PPARG and metabolic dysfunction-associated steatotic liver disease: In line with this finding, a different investigation on subjects with NAFLD revealed that DNA methylation at particular CpG dinucleotides within the human Pparα and Pparγ gene promoters can differentiate between patients with mild from those with severe fibrosis in NAFLD [45].